Today's Daily Dose brings you news about Galera Therapeutics' upcoming milestone, Genetic Technologies' progress on its COVID-19 Severity Risk Test, FDA panel backing of Mallinckrodt 's Terlipressin, PDS Biotech accelerating its PDS0202 vaccine program for influenza and FDA notifying Tricida of deficiencies in the New Drug Application for Veverimer, among others.
from RTT - Biotech https://ift.tt/38Ztasa
via IFTTT
No comments:
Post a Comment